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EdemaMulticellular organisms have developed a variety of mechanisms that allow communication between their
cells. Whereas some of these systems, as neurotransmission or hormones, make possible communication
between remote areas, direct cell-to-cell communication through speciﬁc membrane channels keep in
contact neighboring cells. Direct communication between the cytoplasm of adjacent cells is achieved in
vertebrates by membrane channels formed by connexins. However, in addition to allowing exchange of ions
and small metabolites between the cytoplasms of adjacent cells, connexin channels also communicate the
cytosol with the extracellular space, thus enabling a completely different communication system, involving
activation of extracellular receptors. Recently, the demonstration of connexin at the inner mitochondrial
membrane of cardiomyocytes, probably forming hemichannels, has enlarged the list of actions of connexins.
Some of these mechanisms are also shared by a different family of proteins, termed pannexins. Importantly,
these systems allow not only communication between healthy cells, but also play an important role during
different types of injury. The aim of this review is to discuss the role played by both connexin hemichannels
and pannexin channels in cell communication and injury. This article is part of a Special Issue entitled: The
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Direct cell-to-cell communication through speciﬁc membrane
channels is essential to maintain normal function in several tissues,
as depicted by lack of viability of models devoid of some of these
channels. Direct communication between the cytoplasm of adjacent
cells is achieved in invertebrates by membranes channels formed by a
family of proteins termed innexins, whereas in vertebrates this is
achieved by a different family of proteins termed connexins. However,
in addition to allowing exchange of ions and small metabolites
between the cytoplasms of adjacent cells, connexin channels also
communicate the cytosol with the extracellular space, thus enabling a
completely different communication system, involving activation of
extracellular receptors. More recently, a new family of proteins,
termed pannexins, and sharing some degree of sequence homology
with invertebrate innexins, has been added to the myriad of
vertebrate communication systems. Importantly, these systems
make possible not only communication between healthy cells, but
they also play an important role during injury. The aim of this review
is to summarize existing literature on the role of both connexin
hemichannels and pannexin channels in cell communication, with
special emphasis on their role in cell injury.
2. Cell-to-cell communication through connexin and pannexin
channels during cell injury
Connexins and pannexins have been described to play a role in
cell-to-cell communication between neighboring cells in vertebratesG
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Fig. 1. Role of connexin and pannexin channels in cell injury (see text for details). It is well
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tissues including the heart, as will be discussed in the following
sections. The ﬁrst one involves direct contact between the cytoplasms
of two adjacent cells, thanks to the formation of speciﬁc intercellular
channels formed by connexins. The second one involves the release of
mediators to the extracellular space through connexin hemichannels
and pannexin channels. These mediators would, in turn, activate
speciﬁc receptors located in the plasmalemma of neighboring cells,
giving rise to a speciﬁc response.
2.1. Communication through intercellular channels
Connexins are transmembrane proteins expressed in a variety of
cells, tissues and organs, and play essential roles in different biological
processes, including brain and cardiac development and function. At
least 21 different connexins have been identiﬁed in the human
proteome, having different physiological properties and regulation.
However, all share a similar structure: they have four transmembrane
alpha helices, two extracellular loops and intracellular amino and
carboxyl terminal domains. Whereas intracellular domains are
important for regulation, each extracellular loop possesses three
highly conserved cysteine residues, which are essential for the
formation of functional intercellular channels [1]. However, before
formation of the intercellular channel, each individual cell has to build
its own hemichannel, by oligomerization of six connexin molecules
around a central pore. When the extracellular loops of two
hemichannels from neighboring cells come into contact, the cyto-
plasms of both render connected and an intercellular channel haveNucleus 
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ver, connexins have also other roles on cell injury. Opening of unapposed connexin
ionic gradients. Furthermore, they may potentiate calcium overload induced during
eased metabolites, some, as ATP, NAD+ or glutamate, may have important paracrine
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of cell communication, and that include regulation of water uptake, activation of signal
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cells membranes, forming plaques known as gap junctions. Thus,
connexin intercellular channels in these aggregates are often known
as gap junctional intercellular channels.
The role of gap junction channels in intercellular communication
during cell injury has been reviewed in detail elsewhere [2–7], and
will be only brieﬂy summarized here, focusing mostly on work
addressed to understand the role of connexin-based gap junction
channels in ischemia–reperfusion injury in the heart.
Dead, hypercontracted, cardiomyocytes are found forming aggre-
gates in reperfused infarcts, [8], which suggested the existence of
some type of interaction between them. Spreading of cell death
through gap junctions during myocardial ischemia–reperfusion was
initially supported by studies using heptanol. This gap junction
uncoupler reduced infarct size in pigs when administered at the onset
of reperfusion [9]. This effect was also observed in isolated rat hearts
submitted to ischemia–reperfusion and treated with other chemically
unrelated gap junction uncouplers, as 18α-glycyrrhetinic acid,
palmitoleic acid and halothane [10]. The role of gap junctions in
spreading of cell injury was later conﬁrmed by data obtained in
transgenic micemodels. Replacement of connexin43 (Cx43), themain
connexin isoform in ventricular myocardium, by connexin32, a
connexin isoform mainly expressed in liver, oligodendrocytes,
vascular endothelial cells and Schwann cells, but not in heart, and
having lower channel conductivity and permeability, increases
tolerance to ischemia–reperfusion in isolated mice hearts [11].
Moreover, contrary to the reduction in infarct size observed by
uncoupling gap junctions, an increase in gap junctional communica-
tion induced either by preventing channel closure in mouse hearts
[12], or by increasing the number of channels by overexpression of
Cx32 in mice expressing normal amounts of Cx43 [13], increased
infarction. The mechanisms by which gap junctions propagate injury
are not well known, but they allow passage of metabolites and second
messengers that are involved in cell signaling, such as ATP, ADP,
inositol 1,4,5-triphosphate (IP3) or cAMP. Indeed, in isolated pairs of
cardiomyocytes, hypercontracture has been suggested to propagate
between both cells through passage of sodium ions [14]. Taken
together, these data support a role for gap junctions in spreading of
cell death between neighboring cardiomyocytes. These ﬁndings have
been extended later to other types of injury and tissues [3].
However, other studies have shown conﬂicting results. Treatment
with the antiarrhythmic peptides rotigaptide (ZP123) and Gap-134
improved gap junctional communication, decreased the incidence of
ventricular arrhythmias and reduced infarct size after regional
ischemia–reperfusion in anesthetized rats [15] and dogs [16,17].
Differences between these studies and previous ones are not clear, but
it has been suggested that in these last studies, gap junctions may, in
fact, spread some survival agents between cells or dilute lethal signals
during reperfusion. According to this hypothesis, gap junctions would
link the fate of adjacent myocytes for good or the bad depending
mainly on the severity of injury. Propagation of cell death and of cell
protection through gap junctions has also been described in cell types
other than cardiomyocytes, as in cancer cells [3]. Further studies are
needed to clarify these discrepancies, which can be due, at least in
part, on actions of the mentioned pharmacological agents on
plasmalemmal hemichannels.
Inﬂammation plays a critical role in cell injury. The role of
connexins in the inﬂammatory response is currently well established.
Changes in gap junctional communication have been described in
several inﬂammatory diseases as atherosclerosis, where they play a
role in monocyte adhesion and transmigration, or acute lung
inﬂammation. Furthermore, and as it will be discussed in the
following sections, connexin hemichannels may also play a paracrine
role in the inﬂammatory response by releasing pro-inﬂammatory
factors. To learnmore about the role of connexins in the inﬂammatory
response the reader is referred to several recent reviews [18–21].2.2. Communication through plasmalemmal hemichannels
2.2.1. Role of connexin hemichannels in cell communication and injury
As discussed before, previous studies have highlighted the
importance of gap junctional communication in propagation of
ischemia–reperfusion injury [22,23]. However, most of these studies
do not allow to determine the contribution of unapposed connexin
hemichannels located in the plasma membrane. Such contribution
remains, at present, poorly known, and available information is
mainly restricted to neuronal, glial or endothelial cells.
The presence of unapposed hemichannels outside junctional
plaques was evidenced by biochemical, electrophysiological and dye
uptake studies. Although recent studies have demonstrated that
connexin-based channels have differences in selectivity [24,25], their
main characteristic is their general high conductance and permeabil-
ity. For this reason, it was initially assumed that they should be
normally kept closed to maintain cellular homeostasis, as their
opening would result in membrane depolarization and depletion of
cytoplasmatic metabolites, thus causing cell death. However, now it is
well known that they are submitted to a strict regulation [26,27], and
that their opening controls important functions and may determine
cell death or survival [28]. The differentmechanisms involved in these
effects are discussed below, and include the release of intracellular
messengers and alterations of cell volume.
2.2.1.1. Regulation of connexin hemichannels. Connexin hemichannels
are submitted to a strict regulation by a variety of factors [26,27]. It is
well known that an increase in extracellular calcium concentrations
reduces hemichannel open probability [26,29,30], whereas a decrease
in extracellular calcium has been widely used to induce hemichannel
opening [31,32]. Although the exact mechanisms by which extracel-
lular calcium levels modulate hemichannel gating are not completely
understood, it is known that removal of extracellular calcium
increases pore diameter of Cx43 hemichannels from 1.8 to 2.5 nm
[33]. Furthermore, this effect is not restricted to calcium, as other
divalent cations are also able to gate connexin hemichannels [27,34],
an effect that can bemodulated by changes in redox potential through
S-nitrosylation [35]. Monovalent cations may also modulate hemi-
channel gating, as they potentiate macroscopic Cx50 hemichannel
currents, specially when extracellular calcium is reduced [36].
In addition to extracellular cations, other factors also modulate
connexin hemichannel gating. Hemichannels have a low open
probability in isolated cells under resting conditions at negative
transmembrane potentials, whereas it is increased at positive
potentials [37]. Intracellular pH is also known to gate connexin
hemichannels [38], although this probably depends on the connexin
isoform [39]. Mechanical stimulation induces opening of connexin
hemichannels in osteocytes, as assessed by an increase in ATP release
[40]. But among all known modulators of connexin hemichannels,
conditions mimicking ischemia are, due to their great clinical impact,
of special interest, as will be discussed in the following sections.
2.2.1.2. Direct effects of connexin hemichannels on cell death. Connexin
hemichannels have been suggested to play an important role in cell
injury. Several pathological insults, including ischemia, might induce
opening of connexin hemichannels in different tissues, which would
lead to cell depolarization and collapse of ionic gradients, loss of
intracellular metabolites and cell death. Cx43 hemichannels,
expressed heterologously in HEK293 cells or endogenously in isolated
rabbit adult ventricular cardiomyocytes, showed a marked perme-
ability to calcein and developed large non-selective currents when
cells were exposed to metabolic inhibition [41]. In contrast, non-
transfected HEK293 cells showed much lower staining and currents.
Both effects were blocked by halothane or lanthanum, suggesting an
opening of connexin hemichannels [41]. Similarly, connexin hemi-
channels have been described to open transiently during simulated
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suggested to promote cell injury during simulated reperfusion, as
blockade with Gap26 improved cell viability [42]. These ﬁndings led
some authors to suggest that opened connexin hemichannels may
compromise ionic homeostasis during ischemia, promoting ventric-
ular arrhythmias and myocardial injury [41,43,44]. This hypothesis
has received further support by the recent ﬁnding that treatment,
either before or after ischemia, with the hemichannel inhibitor Gap26,
reduced infarct size in isolated Langendorff-perfused rat hearts
submitted to 40 min of regional ischemia and reperfusion [45].
Opening of hemichannels in response to metabolic inhibition has
been described also in other tissues. Metabolic inhibition induced
permeabilization of rat andmouse cortical astrocytes to Lucifer Yellow
and ethidium bromide, an effect that was reduced by the gap junction
uncouplers octanol and 18α-glycyrrhetinic acid [46]. Furthermore,
ischemia-induced dye uptake was greatly reduced in astrocytes
isolated from mice with targeted deletion of the Cx43 coding DNA,
further conﬁrming the opening of Cx43 hemichannels under energetic
deprivation [46]. The mechanisms that induce hemichannel opening
during simulated ischemia are not well known, but they may involve
dephosphorylation and/or S-nitrosylation of connexins, or a direct
action of reactive oxygen species on the protein [4,35].
In addition to cell depolarization and loss of intracellular
metabolites, opening of hemichannels may have also other important
consequences that would favor cell death. A recent study in HeLa cells
has shown that opening of Cx43 hemichannels may directly mediate
calcium inﬂux induced by extracellular alkalinization [47]. Increasing
extracellular pH from 7.4 to 8.5 increased ethidium uptake, intracel-
lular calcium levels and open probability of Cx43 hemichannels in
cells overexpressing the protein, but not in cells devoid of Cx43, an
effect that was inhibited by connexin hemichannel inhibitors, but not
by pannexin blockers [47]. The inﬂuence that opened connexin
hemichannels may have on intracellular calcium concentrations could
be especially important, as it is well known that alterations in calcium
homeostasis are central components in cell death induced by different
insults, including ischemia–reperfusion injury. Cytosolic Na+ and
Ca2+ overload and cyclic Ca2+ oscillations that occur in reperfused
myocardium after ischemia, in the presence of ATP and pHi
normalization, have been shown to lead to an excessive contractile
activation and to the phenomenon of hypercontracture [48,49].
Hypercontracture causes an excessive shortening in isolated cardio-
myocytes [50], which can cause sarcolemmal rupture in myocardium
and the histologic pattern known as contraction band necrosis in
reperfused myocardium [51]. Furthermore, Ca2+-dependent calpain
activation during early reperfusion impairs the normal function of
Na+/K+-ATPase [52], reducing the capacity of the plasmalemmal
Na+/K+ ATPase to pump Na+ out of the cell, which in turn causes an
additional cytosolic Ca2+ overload through the reverse mode of the
Na+/Ca2+ exchanger [53]. Moreover, upon reperfusion Ca2+ overload
of the mitochondria, together with increased production of reactive
oxygen species (ROS), leads to the opening of MPTP, cytochrome C
release, caspase activation and to apoptosis or necrosis depending on
the circumstances [54].
2.2.1.3. Paracrine signaling through connexin hemichannels. Opening of
connexin hemichannels may also induce the release to the extracel-
lular space of several intracellular metabolites, like ATP or NAD+
[27,55], which may be involved in paracrine signaling. This mecha-
nismmay explain the propagation of calciumwaves in astrocytes [56]
and epithelial cells [57]. In these cells, several stimuli cause increases
in cytosolic calcium concentrations that propagate from cell-to-cell as
a wave. Although different mechanisms may be involved in spreading
of calcium waves [56], several studies have shown that their
propagation requires, at least in some cells, activation of surface
membrane receptors induced by metabolites released from stimulat-
ed cells. In astrocytes and osteocytes, calcium wave propagationdepends, at least in part, on the release of ATP into the extracellular
space [58–61]. ATP would then act on purinergic receptors located in
neighboring cells, thus stimulating IP3 production, and a secondary
increase in intracellular calcium [62]. That connexin hemichannels are
important for ATP release to the extracellular space and intracellular
calcium propagation was demonstrated in endothelial cells treated
with Gap26, a peptide that mimics a 13 amino acid sequence on the
ﬁrst extracellular loop of Cx43 [63]. Gap26 was able to block ATP
release and calcium wave propagation in these cells under conditions
in which this peptide had unnoticeable effects on gap junctional
intercellular communication. Furthermore, treatment of astrocytes
with quinine, that activates some connexin hemichannels, potentiates
ATP release and calcium wave propagation, whereas they are
inhibited by treating cells with several gap junction uncouplers [64].
A similar release of ATP through connexin hemichannels, in tandem
with pannexin channels, has been described in spinal astrocytes after
stimulation with ﬁbroblast growth factor 1 (FGF-1) [65]. Furthermore,
mouse lens Cx23, which is not able to form functional gap junction
channels, enhances ATP release in HeLa cells expressing the protein
[66]. Altogether, these data support a role for connexin hemichannels
in ATP release to the extracellular space and in receptor-mediated
paracrine signaling. In fact, although authors did not analyze the
mechanisms involved, paracrine signaling may explain, in part, the
protection exerted by Gap26 infusion in isolated Langendorff-
perfused rat hearts submitted to 40 min of regional ischemia and
reperfusion [45]. Thus, paracrine signaling can be one of the
mechanisms by which connexin hemichannels may control cell
death and survival through modulation of intracellular calcium levels.
Connexin hemichannels may also modulate cell death by calcium-
independent mechanisms. These mechanisms may involve metabo-
lites that can be released from opened connexin hemichannels,
including NAD+ [67] and glutamate [68,69]. Release of these
metabolites was demonstrated, in ﬁbroblasts and astrocytes, by
blockade of their transmembrane ﬂuxes by incubation with 18α-
glycyrrhetinic acid, antisense oligodeoxynucleotides, or monoclonal
antibodies raised against Cx43 [67,68]. Uncontrolled release of
glutamate is known to trigger excitotoxic necrosis or apoptosis of
neurons [70]. Moreover, the massive release of ATP through opened
hemichannels [58,60,61,71], might also induce apoptosis either
through activation of the pore-forming P2X7 purinergic receptors
[72], or through the rapid accumulation of adenosine, which causes
apoptosis in a neuroblastoma-derived cell line [73]. Further support-
ing the importance of connexin hemichannels on cell injury, it has
been demonstrated that exposure to amyloid-beta peptide render
astrocytes and microglia toxic to neurons exposed to sublethal
hypoxia/reoxygenation episodes through hemichannel-dependent
mechanisms [74]. Exposure to amyloid-beta peptide caused permea-
bilization of cortical neurons through activation of neuronal P2X
receptors and pannexin channels, which, in turn, is induced by ATP
and glutamate released through opened astroglial Cx43 hemichannels
[74,75].
However, some recent ﬁndings may suggest that release of
metabolites through connexin hemichannels may behave as a
double-edged sword. Whereas a sustained release of these metabo-
lites may cause toxic effects through receptor-mediated mechanisms,
including increases in intracellular calcium levels [63,76], or by
induction of apoptosis [72,73], a transient opening of hemichannels
and release of mediators may participate in protective signaling
[77,78]. Lin et al. demonstrated that glial C6 cells devoid of Cx43 were
insensitive to preconditioning, whereas protection in C6 cells over-
expressing Cx43 was attenuated by small interference RNA raised
against Cx43 or by connexin channel blockers [77]. Furthermore,
authors demonstrated that preconditioning protection was linked to a
marked increase in the amount of Cx43 hemichannels and was
mediated by adenosine [77]. These results made authors to suggest
that efﬂux of ATP through connexin hemichannels led to the
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is a known potent protective agent through interactions with their
speciﬁc membrane receptors [79]. However, the role of connexin
hemichannels in preconditioning protection against ischemic injury is
poorly understood, and other authors have suggested that precondi-
tioning may, in fact, inhibit opening of connexin hemichannels during
index ischemia, thus reducing cell death through a decrease in the
cytoplasmatic depletion of metabolites and in the harmful release of
intracellular messengers [80].
2.2.2. Role of pannexin channels in cell communication and injury
Search in the human genome database, using a molluscan innexin
as reference, revealed in 2000 the presence of two putative innexin-
like sequences, that authors called pannexin [81]. Pannexins show
strong similarities at the structural and functional level with
connexins: they are mainly located at the plasma membrane, they
form hexameric structures, and they have a similar membrane
topology, including two extracellular loops, four transmembrane
domains and amino and carboxyl terminal intracellular domains
[82,83]. However, multiple alignments of pannexins have shown that,
in fact, they lack a signiﬁcant degree of homologywith connexins [84].
Among differences, whereas connexins contain three cysteine
residues in their extracellular loops, pannexin contains only two,
thus resembling more to invertebrate innexins [85]. However, some
differences also exist with invertebrate innexins, which may justify
their inclusion in their own family of proteins [82].
At present three different pannexin genes have been identiﬁed in
mammals, expressing three different proteins, Panx1, Panx2 and
Panx3 [84,86,87]. Northern blot analysis of mRNA indicated that
Panx1 and Panx2 were coexpressed in a variety of tissues, including
brain and heart, whereas Panx3 is, at least, expressed in skin, cochlea,
cartilage and bone [84,88–91]. Panx1 channels have a large unitary
conductance of about 500 pS, with at least four substates [92].
Although initial studies proposed that neither Panx2 or Panx3 were
able to form homomeric channels [82], recent studies have suggested
that Panx2 can form homomeric channels in neural progenitor cells,
where it may play a role in cell differentiation [93], whereas Panx3
may function in osteoblasts as a calcium channel in endoplasmic
reticulum, as a channel at the plasmalemma and as an intercellular
channel forming functional gap junctions [89]. Biochemical and
electrophysiological approaches demonstrated that Panx1 can inter-
act with Panx2, although this interaction did not modify pharmaco-
logical sensitivity of the channels [94]. Pannexin channels, contrary to
connexin hemichannels, are not gated by extracellular calcium, and
can open at physiological extracellular calcium concentrations [94]. In
contrast, it has been described that Panx1 channels can be activated
by cytoplasmatic calcium and by extracellular ATP acting through
purinergic receptors of the P2Y group [95].
Due to its relatively recent discovery, the functions of pannexins
are largely unknown. It was initially suggested that they might act as
gap junction proteins, similar to connexins, as they are able to
assemble in Xenopus oocytes into active hemichannels and inter-
cellular channels [84,92]. However, recent evidence indicates that
unlike connexin gap junction intercellular channels, pannexins are
functional in single membranes, but not as intercellular channel in
appositional membranes [96]. For this reason, some authors have
postulated that they should be better referred as channels, but not as
hemichannels [96]. In fact, they may have a similar paracrine function
as that previously described for connexin hemichannels. Thus, Bao et
al. [92] described in Xenopus oocytes that pannexin channels are
mechanosensitive, that they have large conductance, and that are
permeable to ATP. A similar function has been suggested in human
Jurkat T cells [97]. Through the release of ATP, pannexin channels may
play a role in spreading of calcium waves in several tissues [82].
Released ATP can then give rise to a positive feedback, thus activating
more pannexin channels, and inducing an additional ATP release [95].In this way they might, hypothetically, play a role in ischemia–
reperfusion injury. In fact, it has been proposed that neuronal
ischemia may induce opening of Panx1 channels [98]. This role of
pannexin channels may be specially relevant in astrocytes where the
existence of connexin hemichannels remains controversial [99]. In
fact, quantiﬁcation of ATP released from wild-type, Cx43-null, and
Panx1-knock-down astrocytes indicates that downregulation of
Panx1, but not of Cx43, prevented ATP release from these cells,
suggesting that Panx1 are the molecular substrate of astrocyte
hemichannels [99].
Importantly, previous studies have demonstrated that Panx1
channels forms a complex with P2X7 receptors in Xenopus oocytes
[100]. The ionotropic purinergic P2X receptors respond to the ligand
ATP or related agonists by inducing small non-selective cation
currents. However, for certain P2X receptors, as P2X7 receptors,
repeated stimulation leads to the activation of large pores that can
lead to cell death. By playing a role in these P2X7 death complexes,
Panx1 may be of importance in ischemic injury in astrocytes [100]. A
similar Panx1/P2X7 receptor complex has been described in rat hearts,
where they may mediate not only injury, but also the release of
cardioprotectants during both pre- and postconditioning [101,102].
That pannexins may also function as a double-edge sword is further
supported by a recent study in astrocytes showing that ATP released
from Panx1 channels activates P2X7 receptors, which in turn may
result, at least under some circumstances, in closure of Panx1
channels during ischemia [103]. This negative-feedback mechanism
would suppress loss of ATP and calcium inﬂux, thus contributing to
astrocyte survival [103].
Recent studies have suggested that pannexins channels may play a
role in apoptosis [97]. Panx1 has been described to be a target of
effector caspases 3 and 7 in Jurkat T cells. Cleavage by active caspases
would induce Panx1 opening, increasing plasma membrane perme-
ability, and allowing release of ﬁnd-me signals, as ATP or UTP, which,
in turn, would enhance phagocyte recruitment [97]. Furthermore,
thymocytes lacking Panx1, but not P2X7 receptors, have been shown
to be defective in the uptake of the nucleic acid dye YO-PRO-1 during
early apoptosis, and failed to recruit wild-type peritoneal macro-
phages in a Transwell migration assay [104]. Further studies are
needed to understand the role of pannexins in apoptosis and the
nature of released ﬁnd-me signals.
The unexpected discovery of this new family of proteins has
brought a new set of players in the myriad of cell-to-cell communi-
cation systems and has opened a new promising ﬁeld of research.
3. Inﬂuence of connexins and pannexins on cell death
independently of cell-to-cell communication
Connexins and pannexins may inﬂuence cell death independently
of their functions on cell-to-cell communication (Fig. 1). Some of
these effects still depend on their hemichannel structure at the
plasmalemma, as is their inﬂuence on cell volume regulation, or their
role on signaling cascades, but others are dependent on their presence
at different intracellular locations. Due to their recent discovery, most
of these actions have been described for connexins, but an
involvement also of pannexins can not be completely discarded.
3.1. Plasmalemmal, hemichannel-dependent, effects of connexins
3.1.1. Volume regulation
Cell injury has been usually associated with changes in cell
volume. Together with hemorrhage, calcium deposition, and micro-
vascular obstruction, edema is one of the main characteristics of
ischemia–reperfusion injury [105,106]. Although tissue edema is
often associated to changes in extracellular water content, due to the
leakage of macromolecules to the interstitium, it also contains an
intracellular component which is difﬁcult to quantify. Intracellular
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cellular accumulation of end-products of anaerobic metabolism
during ischemia and is increased by the rapid wash-out of the
extracellular space upon reperfusion [107]. However, intracellular
edema may be, in fact, not only a consequence of injury, but it may
also play a role, together with other factors, in cell death, by favoring
plasmalemmal rupture [48,49,107]. For these reasons, cell death is
often described as oncotic cell death [107].
Although the mechanisms responsible for cell swelling are not
completely understood, connexin hemichannels can play an impor-
tant role. The ﬁrst data supporting their involvement in cell volume
regulation came from studies in Xenopus oocytes overexpressing
connexin46 [108]. These cells suffered permeabilization to Lucifer
Yellow and lysis after exposure to low extracellular calcium
concentrations, a condition known to favor hemichannel opening
[26]. That these effects were secondary to water uptake mediated by
opened hemichannels was suggested by its prevention by increasing
the osmotic strength of the extracellular buffer with Ficoll [108].
Furthermore, an increase in extracellular calcium kept connexin
hemichannels closed and prevented oocyte lysis [109]. Later studies
demonstrated that a variety of cell types expressing connexins,
including epithelial, endothelial, neuroblastoma-derived or ﬁbro-
blasts-derived cells, showed signiﬁcant and reversible increases in
volume when extracellular calcium was reduced, an effect that was
prevented by treatment with two different gap junction uncouplers,
oleamide and 18β-glycyrrhetinic acid [32]. Furthermore, the increase
in cell volume did not occur in cells lacking connexins, but could be
restored after Cx43 transfection [32]. Taken together, these data
suggest that connexin hemichannels may play an important role in
volume regulation.
3.1.2. Cell signaling
Connexin hemichannels have been also described to be involved in
signal transduction cascades. Biphosphonate treatment blocks apo-
ptosis induced by dexamethasone in osteoblasts, an effect that
depends on connexin hemichannel integrity and function, but not
on gap junctional communication, as it could be inhibited by
hemichannel blockers in cells plotted at low density [110–112]. That
the effect of biphosphonate treatment depends on opening connexin
hemichannels was demonstrated by the fact that biphosphonates
induced dye uptake, which was prevented by hemichannel blockers,
and they were ineffective in promoting signal cascades in cells
transfected with a dominant negative of Cx43 or in Cx43Δ245
mutants lacking the carboxyl terminal tail of Cx43, both impairing
pore permeability [110,111]. Plotkin et al. demonstrated that
connexin43 hemichannel opening by biphosphonates triggers activa-
tion of the kinases Src and ERKs, and in this way they promote cell
survival [112]. A similar mechanism has been proposed to be
responsible for the gap junction-independent protective effect
induced by forced expression of Cx43, Cx32 or Cx40 in several cell
lines against injury induced by calcium overload, oxidative stress,
metabolic inhibition, tamoxifen and UV irradiation [113]. The role of
connexins in signal transduction cascades is further supported by
proteomic studies demonstrating that Cx43 is able to form signaling
complexes with protein kinase Cε [114]. This role is of great
importance as we have to take in mind that these transduction
pathways have been suggested to be involved in protective maneu-
vers as ischemic pre- and postconditioning [115–117].
3.2. Role of intercellular connexins on cell injury: mitochondrial connexins
Recent studies have demonstrated the presence of Cx43 in
mammalian mitochondria [118–120], where it may modulate cell
death and survival [121]. Although it is not possible to exclude a role
for hemichannels located at the plasma membrane, its mitochondrial
location may explain the essential gap junction-independent role ofCx43 in myocardial protection by ischemic and pharmacological
preconditioning [23,122,123]. Our group demonstrated the presence
of Cx43 in the mitochondria of rat, mouse, pig and human
myocardium, using a complete array of techniques, including ﬂow
cytometry, confocal and immuno-gold electron microscopy, western
blot and proteomic analysis [118,119,124]. This location was later
conﬁrmed by other authors in heart [125–128], brain [129], astrocytes
[130] and bone marrow stem cells [131]. Although the exact location
inside the mitochondria is still debated [127], our own data have
revealed that Cx43 translocates through the TOM (translocase of the
outer mitochondrial membrane)-TIM (translocase of the inner
mitochondrial membrane) system to the inner mitochondrial mem-
brane, in a Hsp90-dependent manner [119], and that it is exclusively
located in subsarcolemmal, but not interﬁbrillar cardiomyocyte
mitochondria [132].
In situ cross-linking studies have demonstrated that mitochondrial
Cx43 forms functional hemichannels at the inner mitochondrial
membrane, that may play a role in controlling mitochondrial
potassium ﬂuxes [124]. However, although the exact functions of
mitochondrial Cx43 are still unknown, some data seem to suggest that
it plays an important role in preconditioning protection. Precondi-
tioning protection, especially with diazoxide, is abolished when Cx43
translocation to the mitochondria is reduced, either by inhibiting
Hsp90 chaperones with geldanamycin [119], or by transgenic
approaches, as in Cx43KI32 knock-in mice, in which the coding
region of Cx43 is replaced by that of Cx32 [133]. In this regard, it has
been suggested that mitochondrial Cx43 may mediate protection by
stimulating mitochondrial ATP-dependent potassium (mitoKATP)
channels, as genetic Cx43 deﬁciency or pharmacological connexin
inhibition by carbenoxolone or Gap27 were able to reduce mitoKATP
single-channel currents induced by diazoxide [134]. Further support-
ing the protective role of mitochondrial Cx43, it has been described
that it may counteract the calcium-induced mitochondrial perme-
ability transition pore opening in rat brainmitochondria, but not in rat
liver mitochondria devoid of it [129], and that mitochondrial-speciﬁc
overexpression of Cx43 exerts protective effects in bonemarrow stem
cells [131]. Efforts are needed to completely elucidate the functions of
mitochondrial Cx43, and its role in cardioprotection.
4. Conclusions
Cell-to-cell communication is achieved in vertebrates by connex-
ins and pannexins, specialized proteins able to form transmembrane
channels. Channels formed by these proteins may participate in cell
injury during ischemia–reperfusion and may allow cell-to-cell
propagation of cell death in myocardium, and possibly of cardiopro-
tective signals. In addition, these proteins may participate in signaling
cascades including those involved in protective pathways. The
presence of connexins in mitochondria appears to have important
consequences in cell physiology as well as in tolerance to ischemia
and preconditioning signaling. The elucidation of actions of connexins
and pannexins other than intercellular communication, their role in
ischemia–reperfusion injury, and their potential interest as therapeu-
tic targets constitutes a new and exciting area of research.
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